To investigate the impact of antiangiogenic monotherapy and photodynamic therapy ( PDT ) as add-on strategy on retinal morphology , and to analyse prognostic biomarkers for visual outcome and retreatment frequency in neovascular age-related macular degeneration ( nAMD ) .